Literature DB >> 33666803

Clinical and pathological analysis of 101 cases of ANCA-associated vasculitic kidney injury.

Shumiao Yang1, Yafang Liu2, Qingfei Xiao1, Chenhao Li1, Hongyue Wang3.   

Abstract

OBJECTIVE: To analyze the clinical and pathological features of patients with anti-neutrophilic cytoplasmic antibody (ANCA)-associated vasculitic (AASV)-kidney injury (AASVKI).
METHODS: From January 2015 to December 2018, a total of 101 AASVKI patients treated in the First Hospital of Jilin University were divided into 2 groups (the pANCA-positive group and the cANCA-positive group) for comparison; 63 patients were performed renal biopsy and divided into 3 groups according to pathological results [the non-crescent nephritis group (non-C), the crescent nephritis group (C), and the sclerotic nephritis group (S)] for comparison.
RESULTS: Compared with the Group pANCA, Group cANCA exhibited higher incidence of eye involvement (P = 0.039) and skin mucosa destruction (P = 0.045), higher serum creatinine (Scr) (P < 0.001), higher 24-h urine protein quantification (P = 0.045), but lower hemoglobin (Hb) (P < 0.001). Compared with Group non-C, Group C had higher Scr (P < 0.001) and urinary red blood cells (P = 0.010), lower estimated glomerular filtration rate (eGFR) (P = 0.003), hemoglobin (HD)-dependence (P = 0.042), and higher mortality rate within 1 year (P = 0.005); compared with Group S, Group C had faster onset of erythrocyte sedimentation rate (ESR) (P = 0.031), higher urinary red blood cells (P = 0.029), and lower incidence of HD-dependence (P = 0.038).
CONCLUSIONS: AASVKI patients with positive cANCA have poor renal function, among whom the patients with crescent type have poorer renal function than those with non-crescent type, have higher urinary red blood cells while lower HD-dependence than those with sclerotic type.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V. part of Springer Nature.

Entities:  

Keywords:  ANCA-associated vasculitic kidney injury; Clinical data; Crescent; Pathology

Mesh:

Year:  2021        PMID: 33666803     DOI: 10.1007/s11255-021-02793-y

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  20 in total

Review 1.  Antineutrophil cytoplasmic antibodies.

Authors:  Xavier Bosch; Antonio Guilabert; Josep Font
Journal:  Lancet       Date:  2006-07-29       Impact factor: 79.321

2.  Clinical outcomes of ANCA-associated vasculitis in elderly patients.

Authors:  Ágnes Haris; Kálmán Polner; József Arányi; Henrik Braunitzer; Ilona Kaszás; István Mucsi
Journal:  Int Urol Nephrol       Date:  2014-04-23       Impact factor: 2.370

Review 3.  Current therapies for ANCA-associated vasculitis.

Authors:  Lindsay Lally; Robert Spiera
Journal:  Annu Rev Med       Date:  2014-10-17       Impact factor: 13.739

4.  Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis.

Authors:  Sophia Lionaki; Elizabeth R Blyth; Susan L Hogan; Yichun Hu; Brent A Senior; Caroline E Jennette; Patrick H Nachman; J Charles Jennette; Ronald J Falk
Journal:  Arthritis Rheum       Date:  2012-10

5.  Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice.

Authors:  Nariaki Asada; Masayuki Takase; Jin Nakamura; Akiko Oguchi; Misako Asada; Norio Suzuki; Ken-ichi Yamamura; Narihito Nagoshi; Shinsuke Shibata; Tata Nageswara Rao; Hans Joerg Fehling; Atsushi Fukatsu; Naoko Minegishi; Toru Kita; Takeshi Kimura; Hideyuki Okano; Masayuki Yamamoto; Motoko Yanagita
Journal:  J Clin Invest       Date:  2011-09-12       Impact factor: 14.808

6.  ANCA-associated glomerulonephritis in the very elderly.

Authors:  Andrew S Bomback; Gerald B Appel; Jai Radhakrishnan; Shayan Shirazian; Leal C Herlitz; Barry Stokes; Vivette D D'Agati; Glen S Markowitz
Journal:  Kidney Int       Date:  2010-12-15       Impact factor: 10.612

Review 7.  Investigations in systemic vasculitis - The role of renal pathology.

Authors:  Annelies E Berden; Maria A C Wester Trejo; Ingeborg M Bajema
Journal:  Best Pract Res Clin Rheumatol       Date:  2018-11-17       Impact factor: 4.098

Review 8.  Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis.

Authors:  Xavier Bossuyt; Jan-Willem Cohen Tervaert; Yoshihiro Arimura; Daniel Blockmans; Luis Felipe Flores-Suárez; Loïc Guillevin; Bernhard Hellmich; David Jayne; J Charles Jennette; Cees G M Kallenberg; Sergey Moiseev; Pavel Novikov; Antonella Radice; Judith Anne Savige; Renato Alberto Sinico; Ulrich Specks; Pieter van Paassen; Ming-Hui Zhao; Niels Rasmussen; Jan Damoiseaux; Elena Csernok
Journal:  Nat Rev Rheumatol       Date:  2017-09-14       Impact factor: 20.543

9.  A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy.

Authors:  Mark Haas; Jacobien C Verhave; Zhi-Hong Liu; Charles E Alpers; Jonathan Barratt; Jan U Becker; Daniel Cattran; H Terence Cook; Rosanna Coppo; John Feehally; Antonello Pani; Agnieszka Perkowska-Ptasinska; Ian S D Roberts; Maria Fernanda Soares; Hernan Trimarchi; Suxia Wang; Yukio Yuzawa; Hong Zhang; Stéphan Troyanov; Ritsuko Katafuchi
Journal:  J Am Soc Nephrol       Date:  2016-09-09       Impact factor: 10.121

10.  Anaemia is an essential complication of ANCA-associated renal vasculitis: a single center cohort study.

Authors:  Tetsuya Kawamura; Joichi Usui; Shuzo Kaneko; Ryoya Tsunoda; Eri Imai; Hirayasu Kai; Naoki Morito; Chie Saito; Michio Nagata; Kunihiro Yamagata
Journal:  BMC Nephrol       Date:  2017-11-25       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.